
ÈÀÌÀÚÀÇÇлó ¾à¸®Çб³½Ç ±èÇü¹ü ºÎ±³¼ö(2017.11.1)
±èÇü¹ü ºÎ±³¼ö°¡ À¯ÀüÀÚ °¡À§ÀÇ ´ë¿ë·® °ËÁõ±â¼úÀ» °³¹ßÇÑ °ø·Î·Î Á¦15ȸ ÈÀÌÀÚÀÇÇлóÀ» ¼ö»óÇÏ¿´½À´Ï´Ù.
´ëÇѹα¹ÀÇÇÐÇѸ²¿øÀÌ ÁÖ°üÇϰí ÈÀÌÀÚÁ¦¾à¿¡¼ ÈÄ¿øÇÏ¿© ±âÃÊ¿Í ÀÓ»óºÐ¾ß¿¡¼ ¶Ù¾î³ Ȱ¾àÀ» ÇÑ ÀÇÇÐÀÚ¿¡°Ô ¼ö¿©ÇÏ´Â »óÀ¸·Î ±èÇü¹ü ºÎ±³¼ö´Â ±âÃÊÀÇÇлóÀ» ¼ö»óÇÏ¿´½À´Ï´Ù.
[¼ö»ó³í¹®]
¡°In vivo high-throughput profiling of CRISPR–Cpf1 activity¡±
Nature Methods 14:153–159, 2017
|
|